no-050328 hydrochloride

Tiagabine hydrochloride (NO050328 hydrochloride) is the hydrochloride salt form of tiagabine, a nipecotic acid derivative with anticonvulsant property. A selective gamma-aminobutyric acid (GABA) reuptake inhibitor.

Tiagabine-D6 Hydrochloride (Standard) is a reference standard of Tiagabine-D6 Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications. Tiagabine-d6 is used as an internal standard when conducting quantitative analysis of Tiagabine using gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry techniques. Tiagabine is an inhibitor of GABA transporter protein 1. It can inhibit the seizures induced by dimethylchloromethane in mice.

Tiagabine-[D5] Hydrochloride (Standard) is a reference standard of Tiagabine-[D5] Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications.

Tiagabine hydrochloride hydrate is a potent and selective inhibitor of GABA uptake, inhibiting [3H] GABA uptake in synaptosomes, neurons, and glia with IC50 values of 67, 446, and 182 nM, respectively. This hydrate can be used as an anticonvulsant.

Tiagabine (NO050328) is an Anti-epileptic Agent. The physiologic effect of tiagabine is by means of Decreased Central Nervous System Disorganized Electrical Activity.

Tiagabine-D6 hydrochloride is intended for use as an internal standard for the quantification of tiagabine by GC- or LC-MS. Tiagabine is an inhibitor of GABA transporter 1. It inhibits seizures induced by DMCM in mice. Tiagabine reduces allodynia in a rodent model of neuropathic pain when used at a dose of 72.8 µmol/kg, and it acts synergistically with gabapentin to delay pain responses in mice in the hot plate test. Formulations containing tiagabine have been used as adjunctive therapies in the treatment of partial seizures.